Preintervention MCP-1 serum levels as an early predictive marker of tumor response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

BACKGROUND: Transarterial chemoembolization (TACE) is a widely accepted treatment for unresectable or intermediate-stage hepatocellular carcinoma (HCC). However, response rates to TACE are heterogeneous and it is not fully understood which patients benefit most from TACE therapy in terms of tumor re...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Ran, Jiang, Hao, Xu, Qingyu, Yin, Guowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797576/
https://www.ncbi.nlm.nih.gov/pubmed/35116424
http://dx.doi.org/10.21037/tcr-20-2791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797576/
https://www.ncbi.nlm.nih.gov/pubmed/35116424
http://dx.doi.org/10.21037/tcr-20-2791

Ejemplares similares